CD274 and neoplasm: Among them, the absence of antigen stimulation signal, expression of other immune checkpoints, the influence of tumor microenvironment, the initial proportion of tumor-infiltrating lymphocytes (TIL), the presence of immunosuppressive cells, and dynamic tumor PD-L1 expression influence the efficacy of immunotherapies [56].